LP
KDNY

LMR Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

LMR Partners’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-164,578
Closed -$6.32M – 1097
2023
Q2 		$6.32M Buy
+164,578
New +$4.23M 0.07% 229

LMR Partners's KDNY Position: Q3 2023 in Review

LMR Partners sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 164,578 shares — an estimated $6.32M sold.

LMR Partners first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $6.32M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • LMR Partners reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 164,578 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.32M.
  • LMR Partners first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • LMR Partners's Chinook Therapeutics, Inc. Common Stock position peaked at $6.32M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.